Abstract:Background: Cancers, a group of multifactorial complex diseases, are generally caused by mutation of multiple genes or dysregulation of pathways. Identifying biomarkers that can characterize cancers would help to understand and diagnose cancers. Traditional computational methods that detect genes differentially expressed between cancer and normal samples fail to work due to small sample size and independent assumption among genes. On the other hand, genes work in concert to perform their functions. Therefore, it is expected that dysregulated pathways will serve as better biomarkers compared with single genes.Results: In this paper, we propose a novel approach to identify dysregulated pathways in cancer based on a pathway interaction network. Our contribution is three-fold. Firstly, we present a new method to construct pathway interaction network based on gene expression, protein-protein interactions and cellular pathways. Secondly, the identification of dysregulated pathways in cancer is treated as a feature selection problem, which is biologically reasonable and easy to interpret. Thirdly, the dysregulated pathways are identified as subnetworks from the pathway interaction networks, where the subnetworks characterize very well the functional dependency or crosstalk between pathways. The benchmarking results on several distinct cancer datasets demonstrate that our method can obtain more reliable and accurate results compared with existing state of the art methods. Further functional analysis and independent literature evidence also confirm that our identified potential pathogenic pathways are biologically reasonable, indicating the effectiveness of our method.Conclusions: Dysregulated pathways can serve as better biomarkers compared with single genes. In this work, by utilizing pathway interaction networks and gene expression data, we propose a novel approach that effectively identifies dysregulated pathways, which can not only be used as biomarkers to diagnose cancers but also serve as potential drug targets in the future.

Revealing Disease Related Interactions by Correlation Analysis

Identifying Disease Genes and Module Biomarkers by Differential Interactions

Relating Diseases Based on Disease Module Theory

The Extraction of Drug-Disease Correlations Based on Module Distance in Incomplete Human Interactome.

Inferring Drug-Disease Associations Based on Known Protein Complexes

Identification of Human Disease Genes from Interactome Network Using Graphlet Interaction.

A Computational Method Based On The Integration Of Heterogeneous Networks For Predicting Disease-Gene Associations

Disease Cluster Detection and Functional Characterization.

Uncovering disease-disease relationships through the incomplete interactome

Identifying Dysregulated Pathways in Cancers from Pathway Interaction Networks

Association Analysis of Proteins Interaction and Genes Co-Regulation

Large-scale analysis of disease pathways in the human interactome

Cluster Correlation Based Method for Lncrna-Disease Association Prediction

Walking the Interactome to Identify Human Mirna-Disease Associations Through the Functional Link Between Mirna Targets and Disease Genes

Identifying Disease Feature Genes Based on Cellular Localized Gene Functional Modules and Regulation Networks

Prediction and interpretation of miRNA-disease associations based on miRNA target genes using canonical correlation analysis

Network-based Analysis of Complex Diseases.

Cross Disease Analysis of Co-Functional Microrna Pairs on a Reconstructed Network of Disease-Gene-microrna Tripartite.

Constructing Disease-Specific Gene Networks Using Pair-Wise Relevance Metric: Application to Colon Cancer Identifies Interleukin 8, Desmin and Enolase 1 As the Central Elements.

Genome-wide Predicting Disease-Related Protein Complexes by Walking on the Heterogeneous Network Based on Data Integration and Laplacian Normalization

Comparative Study of Network-Based Prioritization of Protein Domains Associated with Human Complex Diseases